Cervical Cancer : A Type Of Human Papilloma Virus Essay

Early detection of breast and cervical cancer reduced the burden of disease in women. The practices of Screening shown reduce the level of mortality and improve quality of life. The Every Woman Matters (EWM)stared in 1992 it is a federally-funded program designed to remove barrier to early screening by providing awareness and make screening more financially accessible to woman who have limited or no health insurance. The eligible women receive pay for office visits with associated clinical breast examination, pelvic examination, Papanicolaou smear test, and lab fees (Backer et al., 2004). Age-appropriate mammography and limited number of diagnostic test is also covered under program. In this paper I will

Almost all cervical carcinomas are caused by Human papillomavirus (HPV). Cervical cancer can be a life-threating disease. However, over recent years the occurrence of cervical cancer has declined as well as the chance of dying from it. A huge contributing factor to this decline is the importance of a regular pap smear. A pap smear can find cervical pre-cancer before it turns into cancer. Recently, a vaccine for HPV, has been on the market, which provides close to a 100% protection against pre-cancer and general warts. HPV and cervical cancer are two disease that are closely related. However, each disease effects not only similar populations, but also different populations, as well as having its own signs and symptoms, detection procedures,

The symptoms of cervical cancer are not always obvious thus the introduction of NHS cervical screening programme. The aim of the NHS Cervical Screening Programme is prevent the number women who die from cervical cancer each year due to not having early diagnoses. Since the introduction of the programme, a report was done between the NHS Cervical Screening Programme and Trent Cancer Registry it found that “Incidence and mortality rates in England have fallen considerably over the past 20 years. During this period, incidence rates decreased by over a third and mortality rates reduced by 60%. Survival, following a diagnosis of cervical cancer has improved in England since the 1980’s from the 83% to 88%”. (NHS, 2012, pp. P10-11).

Cervical cancer is the leading cause of cancerous death, in women, since 1950. Approximately 200,000 cervical cancer patients die each year in developing countries. Strains like HPV 16 and 18 cause about 70% of cervical cancer in women– one of the top causes of death in the world (WebMD, 2010, p.1). In the Unites States, about 10,000 women acquire the disease and 3,700 die annually Human Papilloma Virus (HPV) is directly associated as a cause of cervical cancer. This virus affects the skin and genital area and, in some cases, it can also infect the throat and mouth. Since the HPV is passed from one person to another through skin-to-skin or sexual contact, sexually active people are more prone to this virus. Merck

Human Papillomavirus (HPV) is a sexually transmitted virus that spreads from person to person by direct contact of infected tissue. According to the CDC, nearly all men and women will contract HPV at some point in their life (Centers for Disease Control and Prevention [CDC], 2013). HPV can cause cervical, vaginal and vulvar cancers in females. HPV can also cause anal, throat, and neck cancer in both males and females. HPV is also known to cause genital warts in both males and females. According to the National Cancer Institute (2013), “approximately 12,340 new cases of cervical cancer will be diagnosed in the US, and 4,030 US women will die

Cervical cancer is one of the highly popular disease for the women. Different programmes has been made up to fight against this deadly disease. New Zealand has one of the best screening programmes in the world. The establishment of National Cervical Cancer Screening Programme in NZ in 1990 had reduced a significant number of 60% of women who develop cervical cancer and who die from it since it was built. More than 1 million New Zealander women are enrolled in this programme and 95 % are eligible. The Cervical Cancer screening programme aims to; informing women about the importance of having the cervical screening tests; promoting cervical screening tests on a regular basis to women aged 20–70; ensuring high-quality and culturally appropriate services; supporting women with abnormal tests; ensuring there is regular monitoring to see that the goals of the programme are being met. The NCSP also acknowledges the importance of the Treaty of Waitangi in providing a screening programme that is successful for all New Zealand women.

Hispanic women had the highest rate of getting cervical cancer in 2012, followed by black, white, American Indian/Alaska Native, and Asian/Pacific Islander women (Centers for Disease Control and Prevention [CDC], 2013).

The reason for choosing this topic is because, as a nurse practitioner, it is my obligation to play a role in preventing, educating and treating my patients on some of the ways sexually transmitted infections (STI) can be prevented or managed as the case may be. Creating the awareness and educating my patients on the need for routine pap smear. This will help to catch any developing HPV infection in time and start treatment without any delay.

The morbidity and mortality rates for cervical cancer caused by HPV in the United States are 8.1 and 2.4 per 100,000 respectively; worldwide the mortality rate for cervical

Cervical cancer is the second foremost occurring cancer in women after breast cancer. Cervical cancer is a sexually transmitted disease caused by the human papillomavirus, or HPV. Infection by HPV typically occurs in the early years of sexual activity according to the World Health Organization (WHO), but it can take up to a full twenty years for it to develop into a full-blown malignant tumor. Scientists believe that for all intents and purposes all cervical cancer cases are caused by infection with a few types of cancer. Great strides have been made in recent years in the development of a vaccine to treat the cervical cancer. Scientists have cultivated a prophylactic vaccine that would protect against the human papillomavirus. HPV's

Cervical cancer is a physiological disorder that affects a female’s reproductive system (more specifically the womb and the cervix).

Among the 12, 200 new cases of cervical cancer ninety-percent of them are caused or attributed to HPV (ACS).

Cervical cancer is second among the most common cancer that affects women globally. The challenge towards the measures taken to reduce the disease among women is the lack of proper information on the link between the disease itself and the leading cause of it. The disease can be reduced by limiting sexual partners and practicing safe sex, which are challenging and difficult to promote. Therefore, one of the effective ways towards reducing the various cases of cervical cancer is through the HPV vaccination. Most women do not have the information on the connection between cervical cancer and HPV. Consequently, there is the uncertainty among women

A couple of systematic reviews addressing these issues have concluded that there is a need for improvement in the general knowledge about HPV infection and its role as a causative agent in cervical cancer (Cuschieri, Horne, Szarewski, & Cubie, 2006; Klug, Hukelmann, & Blettner, 2008). Studies conducted in adult women show that knowledge about HPV is generally low and that awareness is even lower among high school and college students. Of those who may be aware of HPV, they do not recognize its link with cervical cancer (Anhang, Goodman, & Goldie, 2004). Brewer & Fazekas (2007) used a collection of responses from various studies that specifically examined the awareness and knowledge of HPV to determine an estimate for the level of awareness of HPV among the general American population. While responses varied greatly across studies, approximately 42% of respondents were aware of HPV and 44% were able to correctly identify HPV as being a causative agent for cervical cancer (Brewer & Fazekas,

In the United States, it is one of the eight-most common cancer of women. According to researches, the data shows that Hispanic women are significantly more likely to be diagnosed with cervical cancer than the general population and their median age at diagnosis is 48. In 1998, about 12,800 women were diagnosed in the US and about 4,800 died. Among cancers of the female reproductive tract, it is less common than endometrial cancer and ovarian cancer. The rates of new cases in the United States was 7 per 100,000 women in 2004. Cervical cancer deaths decreased by approximately 74% in the